Document:

Exhibit

March 16, 2017

Juan Andres lm Wygartli 24
Hofstetten 4114 Switzerland

Re:    Employment by ModernaTX, Inc.

Dear Juan,

ModernaTX, Inc. (the “Company”) is pleased to confirm, its offer to employ you as SVP, Technical Development and Manufacturing. Your effective date of hire will be on or before August 1, 2017 (the “Start Date”), and you will perform services for the Company as a regular, full-time employee.
Your initial base salary for this position will be at the rate of $500,000 per year, payable bi-weekly in accordance with the Company’s normal pay schedule. Your salary will be subject to periodic review and adjustments at the Company’s discretion.
You will be eligible to receive an annual performance bonus. The Company will initially target the bonus at up to 50% of your annual salary rate (pro-rated based on your Start Date). The actual bonus percentage is discretionary and will be subject to the Company’s assessment of your performance, as well as business conditions at the Company. The bonus also will be subject to approval by and adjustment at the discretion of the Company and the terms of any applicable bonus plan. You must be employed on the date a bonus is paid to earn that bonus. The Company expects to review your job performance on an annual basis and expects to discuss with you the criteria which the Company will use to assess your performance for bonus purposes.
In addition to the foregoing, upon your commencement of employment with the Company, you will be paid a one-time signing bonus of $300,000 less applicable taxes (the “Signing Bonus”). You will repay a pro rata portion of the Signing Bonus (as calculated by the Company) to the Company if you voluntarily terminate your employment with the Company or your employment is terminated for cause (as determined by the Company) during, in each case, the first 24 months of your employment. That amount may be collected by the Company, either directly or indirectly, from any (i) payment of any kind due to you from the Company or any affiliate thereof including, without 

limitation, accrued wages, vacation, final wages, and expense reimbursements to the fullest extent permitted by applicable law; and/or (ii) the forfeiture or cancellation of any equity interest owned by you in the Company or any subsidiary or affiliate thereof, whether now existing or hereafter formed, and regardless of the form such equity interest (e.g., common units, options to acquire common units or otherwise).
Subject to the commencement of your employment with the Company, the Company will recommend to the Board of Directors (the “Board”) of the Company’s parent entity (“Parent”), that you be eligible to participate in Moderna’s equity incentive program and be granted, at such time as the Board determines, an option to purchase 2,000,000 shares of Parent’s common stock (such equity award is referred to as the “Equity Award”). Subject to the Board’s approval of the Equity Award, the Equity Award will vest according to the following schedule: 25% of the Equity Award will vest on the first anniversary of the Start Date, and the remaining 75% of the Equity Award will vest in equal calendar quarterly installments over the next three years, provided that, in each case, that you continue to provide continuous services to the Company as of each such vesting date. The grant of the Equity Award will be conditioned upon, among other things, your execution of all necessary documentation relating to the Equity Award as determined by the Company (all such documentation is collectively referred to as the “Equity Award Documentation”). The terms and conditions with respect to the Equity Award shall be set forth in the Equity Award Documentation.

The Company will pay reasonable costs associated with your relocation to the Cambridge area from Switzerland consistent with the Employee Relocation Guidelines (the “Relocation Expenses”). The period of temporary accommodation typically allowed will be extended until the end of 2017 in the form of a $5,000 per month allowance for accommodation paid directly by the Company. The Company will determine in its reasonable judgement what, if any, of your Relocation Expenses are for nondeductible expenses in accordance with applicable law and will comply with associated withholding and tax reporting obligations. You will repay the Relocation Expenses to the Company if you voluntarily terminate your employment with the Company or your employment is terminated for cause (as determined by the Company) during the first 12 months of your employment. That amount may be collected by the Company, either directly or indirectly, from any (i) payment of any kind due to you from the Company or any affiliate thereof including, without limitation, accrued wages, vacation, final wages, and expense reimbursements to the fullest extent permitted by applicable law; and/or (ii) the forfeiture or cancellation of any equity interest owned by you in the Company or any subsidiary or affiliate thereof, whether now existing or hereafter formed, and regardless of the form such equity interest (e.g., common units, incentive units (also referred to as profits interests), options to acquire common units or otherwise). In the event that the Company terminate you for any reason other than for voluntary separation or for cause (as determined by the Company), your costs of repatriation to Europe will be covered by the company at the same rate as your inbound trip.

In addition to your compensation, you may take advantage of various benefits offered by the Company. Currently the Company provides group medical and dental insurance, short term disability coverage, group life insurance and a 401(k) plan. These benefits, of course, may be modified, changed or eliminated from time to time at the sole discretion of the Company, and the 

provision of such benefits to you in no way changes or impacts your status as an at-will employee. Where a particular benefit is subject to a formal plan (for example, medical insurance or life insurance), eligibility to participate in and receive any particular benefit is governed solely by the applicable plan document. Should you ever have any questions about Company benefits, you should ask for a copy of the applicable plan document. You will also be eligible for vacation pursuant to the Company’s policies.
All forms of compensation referred to in this offer letter are subject to reduction to reflect applicable withholding and payroll taxes and other deductions required by law.
It is understood that you are an “at-will” employee. You are not being offered employment for a definite period of time, and either you or the Company may terminate the employment relationship at any time and for any reason without prior notice and without additional compensation to you. Similarly, this offer letters sets forth the initial terms and conditions of your employment, which are subject to change at the company’s discretion.
Your normal place of work in 2017 will be Cambridge, Massachusetts; however, it is understood that the Company may change your normal place of work according to the Company’s future needs. When our Norwood, Massachusetts facility is operational, it is expected that you will spend a majority of time in that location. As a condition of your employment, you will need to enter into a “Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement”, a copy of which is enclosed. This offer is conditioned on your representation that you are not subject to any confidentiality, non-competition agreement or any other similar type of restriction that may affect your ability to devote full time and attention to your work at the Company. If you have entered into any agreement that may restrict your activities on behalf of the Company, please provide me with a copy of the agreement as soon as possible. You further represent that you have not used and will not use or disclose any trade secret or other proprietary right of any previous employer or any other party.
The Immigration Reform and Control Act requires employers to verify the employment eligibility and identity of new employees. Enclosed is a copy of the Form I-9 that you will be required to complete. Moderna will support and pay for your O-Visa application. Please bring the appropriate documents listed on that form with you when you report for work. We will not be able to employ you if you fail to comply with this requirement.

Please indicate your acceptance of this offer by signing and dating this letter (PDF by email) and returning it by March 27, 2017.
Juan, we look forward to your joining the Company and are pleased that you will be working with us to build a transformative company for patients.

	
	
	Very truly yours,

	MODERNA, INC.

	 

	By: Stéphane Bancel

	Title: Chief Executive Officer

	 

	/s/ Stéphane Bancel

	
	
	Accepted and Agreed: 

	 

	 

	Juan Andres

	3/17/2017

	DateExhibit 4.2

 

JANUS HENDERSON GROUP PLC

THIRD AMENDED AND RESTATED 2010 DEFERRED INCENTIVE PLAN

 

(effective February 3, 2020)

 

Article 1

 

HISTORY, EFFECTIVE DATE, OBJECTIVES AND DURATION

 

(1)               
History.

 

(a)           
The name of the Plan established and maintained by Janus Henderson Group plc (the “Company”) is the Janus
Henderson Group plc Third Amended and Restated 2010 Deferred Incentive Plan (as may be amended from time to time, the “Plan”).
Janus Capital Group, Inc., a Delaware corporation, originally established the Plan, formally known as the 2010 Long-Term Incentive
Stock Plan, effective April 29, 2010. The Plan was subsequently amended effective December 28, 2011, amended effective April 26,
2012, amended and restated in its entirety effective July 22, 2013, amended effective April 24, 2015, and amended and restated
in its entirety effective May 30, 2017.

 

(b)           
The Plan is hereby amended and restated in its entirety, as set forth herein, effective as of February 3, 2020 (the “Effective
Date”).

 

(2)               
Objectives of the Plan. The Plan is intended to allow employees, directors and consultants of the Company and its Subsidiaries
to acquire or increase equity ownership in the Company, thereby strengthening their commitment to the success of the Company and
stimulating their efforts on behalf of the Company, and to assist the Company and its Subsidiaries in attracting new employees,
directors and consultants and retaining existing employees, directors and consultants. The Plan also is intended to optimize the
profitability and growth of the Company through incentives which are consistent with the Company’s goals; to provide employees,
directors and consultants with an incentive for excellence in individual performance; and to promote teamwork among employees,
directors and consultants.

 

(3)               
Duration of the Plan. The Plan shall commence on the Effective Date and shall remain in effect, subject to the right
of the Board to amend or terminate the Plan at any time pursuant to Article 13 hereof, until the earlier of (a) all Shares subject
to the Plan have been purchased or acquired according to the Plan’s provisions or (b) April 24, 2025. No Awards shall be
granted under the Plan after such termination date.

 

Article 2

 

DEFINITIONS

 

Whenever used in the Plan, the following
terms shall have the meanings set forth below:

 

“Article”
means an Article of the Plan.

 

“Award”
means Options (including Incentive Stock Options), Restricted Shares (awarded as Shares or Share Units), stock appreciation rights
(SARs), Shares or Other Awards granted under the Plan.

 

“Award
Agreement” means the written agreement by which an Award shall be evidenced.

 

“Board”
means the board of directors of the Company.

 

     

     

    

 

“Cause”
shall have the meaning set forth in a Grantee’s Award Agreement, or if not defined therein, the meaning set forth in
the Grantee’s individual employment or services agreement between the Grantee and the Company or a Subsidiary, or if
the Grantee is not a party to an employment or services agreement in which Cause is defined, as follows:

 

(a)                
a Grantee’s commission of a crime which, in the judgment of the Committee, resulted or is likely to result in damage
or injury to the Company or a Subsidiary;

 

(b)               
the material violation by the Grantee of written policies of the Company or a Subsidiary;

 

(c)                
the habitual neglect or failure by the Grantee in the performance of his or her duties to the Company or a Subsidiary (but
only if such neglect or failure is not remedied within a reasonable remedial period after Grantee’s receipt of written notice
from the Company which describes such neglect or failure in reasonable detail and specifies the remedial period); or

 

(d)               
action or inaction by the Grantee in connection with his or her duties to the Company or a Subsidiary resulting, in the
judgment of the Committee, in material injury to the Company or a Subsidiary.

 

“Code”
means the Internal Revenue Code of 1986, as amended from time to time, and regulations and rulings thereunder. References to a
particular section of the Code include references to successor provisions of the Code or any successor code.

 

“Committee”
has the meaning set forth in Article 3.

 

“Common
Stock” means an ordinary share, $1.50 par value, of the Company.

 

“Company”
has the meaning set forth in Section 1.1(a) and shall include the Company’s permitted successors and assigns.

 

“Disability”
means, unless otherwise defined in the Award Agreement, that a Grantee (i) is unable to engage in any substantial gainful activity
by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected
to last for a continuous period of not less than 12 months, or (ii) is, by reason of any medically determinable physical or mental
impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months,
receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering
employees of the Company or a Subsidiary of the Company.

 

“Disqualifying
Disposition” has the meaning set forth in Section 6.4.

 

“Dividend
Equivalents” has the meaning set forth in Section 12.3.

 

“Effective
Date” shall have the meaning set forth in Section 1.1(b).

 

“Eligible
Person” means (i) any employee (including any officer) of the Company or any Subsidiary, including any such employee
who is on an approved leave of absence, layoff, or has been subject to a disability which does not qualify as a Disability, (ii)
any director of the Company or any Subsidiary and (iii) any person performing services for the Company or a Subsidiary in the capacity
of a consultant or otherwise.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended from time to time. References to a particular section
of the Exchange Act include references to successor provisions.

 

“Fair
Market Value” means (A) with respect to any property other than Shares, the fair market value of such
property determined by such methods or procedures as shall be established from time to time by the Committee, and (B) with
respect to Shares, unless otherwise determined by the Committee, as of any date, (i) the average of the high and low trading
prices on the date of determination on the New York Stock Exchange (or, if no sale of Shares was reported for such date, on
the next succeeding date on which a sale of Shares was reported); (ii) if the Shares are not listed on the New York Stock
Exchange, the average of the high and low trading prices of the Shares on such other national exchange on which the Shares
are principally traded or as reported by the National Market System, or similar organization, or if no such quotations are
available, the average of the high bid and low asked quotations in the over-the-counter market as reported by the National
Quotation Bureau Incorporated or similar organizations; or (iii) in the event that there shall be no public market for the
Shares, the fair market value of the Shares as determined by the Committee.

 

    2

     

    

 

“Freestanding
SAR” means an SAR that is granted independently of any other Award.

 

“Grant
Date” has the meaning set forth in Section 5.2.

 

“Grantee”
means an individual who has been granted an Award.

 

“Incentive
Stock Option” means an option granted under Article 6 of the Plan that is intended to meet the requirements of
Section 422 of the Code or any successor provisions thereto.

 

“including”
or “includes” means “including, without limitation,” or
 “includes, without limitation,” respectively.

 

“Management
Committee” has the meaning set forth in Article 3.

 

“Option”
means an option granted under Article 6 of the Plan.

 

“Other Awards” means
an Award granted under Article 9 of the Plan, including mutual fund units or cash awards earned upon the attainment of performance
goals or otherwise as permitted under the Plan.

 

“Performance
Measures” means the criteria and objectives, determined by the Committee, which must be met during the applicable
Performance Period as a condition of the Grantee’s receipt of payment with respect to an Award. Performance measures may
include any or all of the following or any combination thereof: (a) stock price; (b) market share; (c) sales (gross or net); (d)
asset quality; (e) non-performing assets; (f) earnings per share; (g) return on equity; (h) costs; (i) operating income; (j) net
income; (k) marketing-spending efficiency; (l) return on operating assets; (m) return on assets; (n) core non-interest income;
(o) fund performance; (p) pre-tax margin; (q) pre-tax income; (r) levels of cost savings; (s) operating margin; (t) flows into
Company products (gross or net), (u) earnings, (v) earnings before interest, taxes, depreciation and amortization, (w) improvements
in productivity and objective operating goals. Any of the foregoing performance measures may be applied, as determined by the Committee,
in respect of the Company or any of its Subsidiaries, affiliates, business units or divisions and/or the Company’s or any
of its Subsidiaries, affiliates, business units or divisions worldwide, regional or country specific operations (or any combination
of the foregoing) and/or (x) other performance metrics as determined by the Committee. Performance measures shall specify whether
they are to be measured relative to budgeted or other internal goals, operations, performance or results of the Company and/or
any of its Subsidiaries, affiliates, business units or divisions, or relative to the performance of one or more peer groups of
the Company and/or any of its Subsidiaries, affiliates, business units or divisions, with the composition of any such peer groups
to be determined by the Committee at the time the performance measure is established. Performance measures may be stated in the
alternative or in combination. The Committee shall have the right but not the obligation to make adjustments to a performance measure
to take into account any unusual or extraordinary events. In the event that applicable tax and/or securities laws change to permit
Committee discretion to alter the governing performance measures without obtaining stockholder approval of such changes, the Committee
shall have sole discretion to make such changes without obtaining stockholder approval.

 

“Performance
Period” means the time period during which the Performance Measures must be met.

 

“Person”
shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13 (d) and 14(d) thereof,
including a “group” as defined in Section 13(d) thereof.

 

“Plan”
has the meaning set forth in Section 1.1(a).

 

    3

     

    

 

“Plan
Committee” has the meaning set forth in Article 3.

 

“Restricted
Shares” means Shares or Share Units that are subject to forfeiture if the Grantee does not satisfy the conditions
specified in the Award Agreement applicable to such Shares or Share Units.

 

“Rule
16b-3” means Rule 16b-3 promulgated by the SEC under the Exchange Act, as amended from time to time, together
with any successor rule, as in effect from time to time.

 

“SAR”
means a stock appreciation right.

 

“SEC”
means the United States Securities and Exchange Commission, or any successor thereto.

 

“Section”
means, unless the context otherwise requires, a Section of the Plan.

 

“Section
16 Person” means a person who is subject to potential liability under Section 16(b) of the Exchange Act with respect
to transactions involving equity securities of the Company.

 

“Share”
means a share of Common Stock.

 

“Share
Unit” means a bookkeeping entry representing the equivalent of one share of Common Stock that is payable in the
form of Common Stock, cash, or any combination of the foregoing.

 

“Strike
Price” of any SAR shall equal, for any Tandem SAR (whether such Tandem SAR is granted at the same time as or after
the grant of the related Option), the option price of such Option, or for any other SAR, 100 percent of the Fair Market Value of
a Share on the Grant Date of such SAR; provided that the Committee may specify a higher Strike Price in the Award Agreement.

 

“Subsidiary”
means a United States or foreign corporation or limited liability company, partnership or other similar entity with respect to
which the Company owns, directly or indirectly, 50 percent or more of the Voting Power of such corporation, limited liability company,
partnership or other similar entity.

 

“Tandem
SAR” means an SAR that is granted in connection with a related Option, the exercise of which shall require cancellation
of the right to purchase a Share under the related Option (and when a Share is purchased under the related Option, the Tandem SAR
shall similarly be canceled).

 

“Termination
of Affiliation” occurs on the first day on which an individual is for any reason no longer an employee, director
or consultant of the Company or any Subsidiary, or with respect to an individual who is an employee or director of, or consultant
to, a corporation which is a Subsidiary, the first day on which such corporation ceases to be a Subsidiary; provided, however,
that for each Award subject to Section 409A of the Code, a Termination of Affiliation shall be deemed to have occurred under this
Plan with respect to such Award on the first day on which an individual has experienced a “separation from service”
within the meaning of Section 409A of the Code.

 

“10%
Owner” means a person who owns capital stock (including stock treated as owned under Section 424(d) of the Code)
possessing more than 10 percent of the total combined Voting Power of all classes of capital stock of the Company or any Subsidiary.

 

“Voting
Power” means the combined voting power of the then-outstanding securities of a corporation entitled to vote generally
in the election of directors.

 

    4

     

    

 

Article 3

 

ADMINISTRATION

 

(1)               
Committee.

 

(a)           
Subject to Article 13 and to Section 3.2, the Plan shall be administered by the Board, or a committee appointed by the Board
to administer the Plan (the “Plan Committee”). To the extent the Board
considers it desirable to comply with or qualify under Rule 16b-3, the Plan Committee shall consist of two or more directors of
the Company, all of whom qualify as “non-employee directors” (as defined within the meaning of Rule 16b-3). The number
of members of the Plan Committee shall from time to time be increased or decreased, and shall be subject to such conditions, in
each case as the Board deems appropriate to permit transactions in Shares pursuant to the Plan to satisfy such conditions of Rule
16b-3 as then in effect.

 

(b)           
The Board or the Plan Committee may appoint and delegate to another committee consisting of one or more persons (“Management
Committee”) any or all of the authority of the Board or the Committee, as applicable, with respect to Awards to
Grantees other than Grantees who are Section 16 Persons at the time any such delegated authority is exercised.

 

(c)           
Any references herein to “Committee” are references to the Board,
or the Plan Committee or the Management Committee, as applicable.

 

(2)               
Powers of Committee.

 

Subject to the express provisions of the
Plan, the Committee has full and final authority and sole discretion as follows:

 

(a)           
to determine when, to whom and in what types and amounts Awards should be granted and the terms and conditions applicable
to each Award, including the benefit payable under any SAR, and whether or not specific Awards shall be granted in connection with
other specific Awards, and if so whether they shall be exercisable cumulatively with, or alternatively to, such other specific
Awards;

 

(b)           
to determine the amount, if any, that a Grantee shall pay for Restricted Shares, whether to permit or require the payment
of cash dividends thereon to be deferred and the terms related thereto, when Restricted Shares (including Restricted Shares acquired
upon the exercise of an Option) shall be forfeited and whether such Shares shall be held in escrow;

 

(c)           
to construe and interpret the Plan and to make all determinations necessary or advisable for the administration of the Plan;

 

(d)           
to make, amend, and rescind rules relating to the Plan, including rules with respect to the exercisability and non-forfeitability
of Awards upon the Termination of Affiliation of a Grantee;

 

(e)           
to determine the terms and conditions of all Award Agreements (which need not be identical) and, with the consent of the
Grantee, to amend any such Award Agreement at any time, among other things, to permit transfers of such Awards to the extent permitted
by the Plan; provided that the consent of the Grantee shall not be required for any amendment which (i) does not adversely
affect the rights of the Grantee, or (ii) is necessary or advisable (as determined by the Committee) to carry out the purpose of
the Award as a result of any new or change in existing applicable law;

 

(f)            
to cancel, with the consent of the Grantee, outstanding Awards and to grant new Awards in substitution therefore;

 

(g)            to
accelerate the exercisability (including exercisability within a period of less than six months after the Grant Date) or the
vesting of, and to accelerate or waive any or all of the terms and conditions applicable to, any Award or any group of Awards
for any reason and at any time, including in connection with a Termination of Affiliation or any event described in Section
4.2;

 

    5

     

    

 

(h)           
subject to Section 5.3, to extend the time during which any Award or group of Awards may be exercised;

 

(i)            
to make such adjustments or modifications to Awards to Grantees working outside the United States as are advisable to fulfill
the purposes of the Plan or to comply with applicable local law;

 

(j)            
to impose such additional terms and conditions upon the grant, exercise or retention of Awards as the Committee may, before
or concurrently with the grant thereof, deem appropriate, including limiting the percentage of Awards which may from time to time
be exercised by a Grantee; and

 

(k)           
to take any other action with respect to any matters relating to the Plan for which it is responsible.

 

All determinations on all matters relating
to the Plan or any Award Agreement may be made in the sole and absolute discretion of the Committee, and all such determinations
of the Committee shall be final, conclusive and binding on all Persons. No member of the Committee shall be liable for any action
or determination made with respect to the Plan or any Award.

 

Article 4

 

SHARES SUBJECT TO THE PLAN AND MAXIMUM AWARDS

 

(1)               
Number of Shares Available for Grants. Subject to adjustment as provided in Section 4.2, the number of Shares hereby
reserved for issuance under the Plan shall be 10,000,000, all of which may be granted as Incentive Stock Options (plus an unlimited
amount of mutual fund units and other Awards not denominated in Shares). Notwithstanding anything herein to the contrary, all Shares
subject to a SAR award that are settled in Shares shall be counted in full against the number of Shares reserved for issuance under
the Plan. If any Shares subject to an Award granted hereunder are forfeited, terminated, expired or canceled or such Award otherwise
terminates without the issuance of such Shares or of other consideration in lieu of such Shares, the Shares subject to such Award,
to the extent of any such forfeiture, termination, expiration or cancellation shall again be available for grant under the Plan
(without a charge against the aggregate number of Shares available for issuance hereunder). Notwithstanding the foregoing, Shares
surrendered or withheld as payment of either the Strike Price of an Award (including Shares otherwise underlying an Award of a
SAR that are retained by the Company to account for the grant price of such SAR) and/or withholding taxes in respect of an Award
shall no longer be available for grant under the Plan. The Committee may from time to time determine the appropriate methodology
for calculating the number of Shares (i) issued pursuant to the Plan, and (ii) granted to any Grantee pursuant to the Plan. Shares
issued pursuant to the Plan may be treasury Shares, newly-issued Shares, Shares issued from a trust or Shares purchased on the
market.

 

(2)                Adjustments
in Authorized Shares. In the event that the Committee determines that any dividend or other distribution (whether in the
form of cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, subdivision,
consolidation or reduction of capital, reorganization, merger, split-up, spin-off or combination involving the Company or
repurchase or exchange of Shares or other rights to purchase Shares or other securities of the Company, or other similar
corporate transaction or event affects the Shares such that any adjustment is determined by the Committee to be appropriate
in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the
Plan, then the Committee shall, in such manner as it may deem equitable, adjust any or all of (i) the number and type of
Shares (or other securities or property) with respect to which Awards may be granted; (ii) the number and type of Shares (or
other securities or property) subject to outstanding Awards; and (iii) the grant or exercise price with respect to any Award
or, if deemed appropriate, cancel an outstanding Award, in exchange for, if deemed appropriate, a cash payment to the holder
of an outstanding Award or the substitution of other property for Shares subject to an outstanding Award; provided, in
each case that with respect to Awards of Incentive Stock Options no such adjustment shall be authorized to the extent that
such adjustment would cause the Plan to violate Section 422(b)(1) of the Code or any successor provision thereto; and provided
further, that with respect to Options and SARs, such adjustment shall be made in accordance with the provisions of
Section 424(h) of the Code; and, provided further, that the number of Shares subject to any Award denominated in
Shares shall always be a whole number.

 

    6

     

    

 

 

Article 5

ELIGIBILITY AND GENERAL CONDITIONS OF AWARDS

 

(1)               
Eligibility. The Committee may grant Awards to any Eligible Person, whether or not he or she has previously received
an Award.

 

(2)               
Grant Date. The “Grant Date” of an Award shall be the date
on which the Committee grants the Award or such later date as specified by the Committee.

 

(3)               
Maximum Term. Except with respect to an Option Award, the term during which an Award may be outstanding shall under
no circumstances extend more than 10 years after the Grant Date and shall be subject to earlier termination as herein provided.

 

(4)               
Minimum Vesting Period. Subject to Section 5.7 of the Plan, all Awards granted under the Plan resulting in the issuance
of Shares under the Plan (other than (i) Awards that an Eligible Person purchases for their Fair Market Value (including Awards
that an Eligible Person elects to receive in lieu of fully vested compensation that is otherwise due) and (ii) Awards granted to
non-employee directors of the Company or any Subsidiary, which together shall not exceed more than five percent (5%) of the Shares
reserved for issuance under the Plan) shall be granted subject to a minimum vesting period of at least twelve (12) months.

 

(5)               
Award Agreement. To the extent not set forth in the Plan, the terms and conditions of each Award (which need not be
the same for each grant or for each Grantee) shall be set forth in an Award Agreement.

 

(6)               
Restrictions on Share Transferability. The Committee may impose such restrictions on any Shares acquired pursuant to
the exercise or vesting of an Award as it may deem advisable, including restrictions under applicable federal securities laws.

 

(7)               
Termination of Affiliation. Except as otherwise provided by the Committee, and subject to Section 13.3, the extent to
which the Grantee shall have the right to exercise, vest in, or receive payment in respect of an Award following Termination of
Affiliation shall be set forth in the applicable Award Agreement.

 

(8)               
Non-transferability of Awards.

 

(a)           
Except as provided in Section 5.8(c) below or as otherwise determined by the Committee, each Award, and each right under
any Award, shall be exercisable only by the Grantee during the Grantee’s lifetime, or, if permissible under applicable law,
by the Grantee’s guardian or legal representative.

 

(b)           
Except as provided in Section 5.8(c) below or as otherwise determined by the Committee, no Award (prior to the time, if
applicable, Shares are issued in respect of such Award), and no right under any Award, may be assigned, alienated, pledged, attached,
sold or otherwise transferred or encumbered by a Grantee otherwise than by will or by the laws of descent and distribution (or
in the case of Restricted Shares, to the Company), and any such purported assignment, alienation, pledge, attachment, sale, transfer
or encumbrance shall be void and unenforceable against the Company or any Subsidiary; provided, that the designation of
a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance.

 

(c)            To
the extent and in the manner permitted by the Committee, and subject to such terms, conditions, restrictions or limitations
that may be prescribed by the Committee, a Grantee may transfer an Award (other than an Incentive Stock Option) to (i) a
spouse, sibling, parent, child (including an adopted child) or grandchild (any of which, an “Immediate
Family Member”) of the Grantee; (ii) a trust, the primary beneficiaries of which consist exclusively of the
Grantee or Immediate Family Members of the Grantee; or (iii) a corporation, partnership or similar entity, the owners of
which consist exclusively of the Grantee or Immediate Family Members of the Grantee.

 

    7

     

    

 

(9)               
Cancellation and Rescission of Awards. Unless the Award Agreement specifies otherwise, the Committee may cancel, rescind,
suspend, withhold, or otherwise limit or restrict any unexercised Award at any time if the Grantee is not in compliance with all
applicable provisions of the Award Agreement and the Plan or if the Grantee has a Termination of Affiliation for Cause.

 

Article 6

STOCK OPTIONS

 

(1)               
Grant of Options. Subject to the terms and provisions of the Plan, Options may be granted to any Eligible Person in
such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee. Without in any
manner limiting the generality of the foregoing and in a manner intended to comply with Section 409A of the Code, the Committee
may grant to any Eligible Person, or permit any Eligible Person to elect to receive, an Option in lieu of or in substitution for
any other compensation (whether payable currently or on a deferred basis, and whether payable under this Plan or otherwise) which
such Eligible Person may be eligible to receive from the Company or a Subsidiary.

 

(2)               
Award Agreement. Each Option grant shall be evidenced by an Award Agreement that shall specify the option price, the
option term, the number of Shares to which the Option pertains, the time or times at which such Option shall be exercisable and
such other provisions as the Committee shall determine. In no event shall the Option be exercisable for a period of more than seven
(7) years from its Grant Date, provided that it may be subject to earlier termination as provided herein or in the applicable Award
Agreement.

 

(3)               
Option Price. The option price of an Option under this Plan shall be determined by the Committee, and shall be equal
to or more than 100 percent of the Fair Market Value of a Share on the Grant Date; provided, however, that any Option that is (x)
granted to a Grantee in connection with the acquisition (“Acquisition”),
however effected, by the Company of another corporation or entity (“Acquired Entity”)
or the assets thereof, (y) associated with an option to purchase shares of stock of the Acquired Entity or an affiliate thereof
(“Acquired Entity Option”) held by such Grantee immediately prior to
such Acquisition, and (z) intended to preserve for the Grantee the economic value of all or a portion of such Acquired Entity Option
(“Substitute Option”) may, to the extent necessary to achieve such
preservation of economic value, be granted with an option price that is less than 100 percent of the Fair Market Value of a Share
on the Grant Date, provided that such grant is made in a manner that will not result in the Substitute Option being subject to
the requirements of Section 409A of the Code.

 

(4)               
Grant of Incentive Stock Options. At the time of the grant of any Option, the Committee may designate that such Option
shall be made subject to additional restrictions to permit it to qualify as an “incentive stock option” under the requirements
of Section 422 of the Code. Any Option designated as an Incentive Stock Option shall (to the extent required by Section 422 of
the Code):

 

(a)           
if granted to a 10% Owner, have an option price not less than 110 percent of the Fair Market Value of a Share on its Grant
Date;

 

(b)           
be exercisable for a period of not more than seven (7) years (five years in the case of an Incentive Stock Option granted
to a 10% Owner) from its Grant Date, and be subject to earlier termination as provided herein or in the applicable Award Agreement;

 

(c)           
not have an aggregate Fair Market Value (as of the Grant Date of each Incentive Stock Option) of the Shares with respect
to which Incentive Stock Options (whether granted under the Plan or any other stock option plan of the Grantee’s employer
or any parent or Subsidiary thereof (“Other Plans”)) are exercisable
for the first time by such Grantee during any calendar year, determined in accordance with the provisions of Section 422 of the
Code, which exceeds $100,000 (the “$100,000 Limit”);

 

    8

     

    

 

(d)           
if the aggregate Fair Market Value of the Shares (determined on the Grant Date) with respect to the portion of such grant
which is exercisable for the first time during any calendar year (“Current Grant”)
and all Incentive Stock Options previously granted under the Plan and any Other Plans which are exercisable for the first time
during the same calendar year (“Prior Grants”) would exceed the $100,000
Limit, be exercisable as follows:

 

(1)         
the portion of the Current Grant which would, when added to any Prior Grants, be exercisable with respect to Shares which
would have an aggregate Fair Market Value (determined as of the respective Grant Date for such options) in excess of the $100,000
Limit shall, notwithstanding the terms of the Current Grant, be exercisable for the first time by the Grantee in the first subsequent
calendar year or years in which it could be exercisable for the first time by the Grantee when added to all Prior Grants without
exceeding the $100,000 Limit; and

 

(2)         
if, viewed as of the date of the Current Grant, any portion of a Current Grant could not be exercised under the preceding
provisions of this Section during any calendar year commencing with the calendar year in which it is first exercisable through
and including the last calendar year in which it may by its terms be exercised, such portion of the Current Grant shall not be
an Incentive Stock Option, but shall be exercisable as an Option which is not an Incentive Stock Option at such date or dates as
are provided in the Current Grant;

 

(e)           
be granted within seven (7) years from the earlier of the date the Plan is adopted or the date the Plan is approved by the
stockholders of the Company; and

 

(f)            
by its terms not be assignable or transferable other than by will or the laws of descent and distribution and may be exercised,
during the Grantee’s lifetime, only by the Grantee; provided, however, that the Grantee may, in any manner
permitted by the Plan and specified by the Committee, designate in writing a beneficiary to exercise his or her Incentive Stock
Option after the Grantee’s death.

 

Any Option designated as an Incentive Stock
Option shall also require the Grantee to notify the Committee of any disposition of any Shares issued pursuant to the exercise
of the Incentive Stock Option under the circumstances described in Section 421(b) of the Code (relating to certain disqualifying
dispositions) (any such circumstance, a “Disqualifying Disposition”),
within 10 days of such Disqualifying Disposition.

 

Notwithstanding Section 3.2(e), the Committee
may, without the consent of the Grantee, at any time before the exercise of an Option (whether or not an Incentive Stock Option),
take any action necessary to prevent such Option from being treated as an Incentive Stock Option.

 

(5)               
Payment. Options granted under this Article 6 shall be exercised by the delivery of a written notice of exercise to
the Company, setting forth the number of Shares with respect to which the Option is to be exercised, accompanied by full payment
for the Shares made by any one or more of the following means, subject to the approval of the Management Committee (or the Committee
to the extent required by Section 16(b) of the Exchange Act):

 

(a)           
cash, personal check or wire transfer;

 

(b)           
Shares valued at their Fair Market Value on the date of exercise;

 

(c)           
Restricted Shares, each such Share valued at the Fair Market Value of a Share on the date of exercise; or

 

(d)           
subject to applicable law, pursuant to procedures approved by the Committee, through the sale of the Shares acquired on
exercise of the Option, valued at their Fair Market Value in the date of exercise, sufficient to pay for such Shares, together
with, if requested by the Company, the amount of federal, state, local or foreign withholding taxes payable by Grantee by reason
of such exercise.

 

    9

     

    

 

If any Restricted Shares (“Tendered
Restricted Shares”) are used to pay the option price, a number of Shares acquired on exercise of the Option equal
to the number of Tendered Restricted Shares shall be subject to the same restrictions as the Tendered Restricted Shares, determined
as of the date of exercise of the Option.

 

Article 7

STOCK APPRECIATION RIGHTS

 

(1)               
Grant of SARs. Subject to the terms and conditions of the Plan, SARs may be granted to any Eligible Person at any time
and from time to time as shall be determined by the Committee. The Committee may grant Freestanding SARs, Tandem SARs, or any combination
thereof. The Committee shall determine the number of SARs granted to each Grantee (subject to Article 4), the Strike Price thereof,
and, consistent with Section 7.2 and the other provisions of the Plan, the other terms and conditions pertaining to such SARs.
The Strike Price shall be determined by the Committee, and shall be equal to or more than 100 percent of the Fair Market Value
of a Share on the Grant Date; provided, however, that any SAR that is (x) granted to a Grantee in connection with an Acquisition,
however effected, by the Company of an Acquired Entity or the assets thereof, (y) associated with a stock appreciation right in
respect of shares of stock of the Acquired Entity or an affiliate thereof (“Acquired
Entity SAR”) held by such Grantee immediately prior to such Acquisition, and (z) intended to preserve for the
Grantee the economic value of all or a portion of such Acquired Entity SAR (“Substitute
SAR”) may, to the extent necessary to achieve such preservation of economic value, be granted with a Strike Price
that is less than 100 percent of the Fair Market Value of a Share on the Grant Date, provided that such grant is made in a manner
that will not result in the Substitute SAR being subject to the requirements of Section 409A of the Code.

 

(2)               
Exercise of Tandem SARs. Tandem SARs may be exercised for all or part of the Shares subject to the related Award upon
the surrender of the right to exercise the equivalent portion of the related Award. A Tandem SAR may be exercised only with respect
to the Shares for which its related Award is then exercisable. Notwithstanding any other provision of this Plan to the contrary,
with respect to a Tandem SAR, (i) the Tandem SAR will expire no later than the expiration of the underlying Option; (ii) the value
of the payout with respect to the Tandem SAR may be for no more than 100 percent of the difference between the option price of
the underlying Option and the Fair Market Value of the Shares subject to the underlying Option at the time the Tandem SAR is exercised;
and (iii) the Tandem SAR may be exercised only when the Fair Market Value of the Shares subject to the Option exceeds the option
price of the Option.

 

(3)               
Payment of SAR Amount. Upon exercise of an SAR, the Grantee shall be entitled to receive payment from the Company in
an amount determined by multiplying:

 

(a)           
the excess of the Fair Market Value of a Share on the date of exercise over the Strike Price; by

 

(b)           
the number of Shares with respect to which the SAR is exercised;

 

provided that the Committee may provide in the Award Agreement
that the benefit payable on exercise of an SAR shall not exceed such percentage of the Fair Market Value of a Share on the Grant
Date as the Committee shall specify. As provided by the Committee in the Award Agreement, the payment upon exercise of a Freestanding
SAR or Tandem SAR shall either be in Shares which have an aggregate Fair Market Value (as of the date of exercise of the SAR) equal
to the amount of the payment or cash.

 

Article 8

RESTRICTED SHARES

 

(1)               
Grant of Restricted Shares. Subject to the terms and provisions of the Plan, the Committee, at any time and from time
to time, may grant Restricted Shares to any Eligible Person in such amounts as the Committee shall determine.

 

    10

     

    

 

(2)               
Award Agreement. Each grant of Restricted Shares shall be evidenced by an Award Agreement that shall specify the period(s)
of restriction, the number of Restricted Shares granted, and such other provisions as the Committee shall determine including,
with respect to each Restricted Share that is also a Share Unit, the time and form of payment of such Restricted Share; provided,
however, that with respect to Restricted Shares that are also Share Units, if such Share Units would be subject to Section 409A
of the Code, the provisions of such Share Unit shall comply with the requirements set forth in Section 409A of the Code.

 

(3)               
Restrictions. The Committee may impose such conditions and/or restrictions on any Restricted Shares granted pursuant
to the Plan as it may deem advisable, including restrictions based upon the achievement of Performance Measures, the achievement
of individual performance goals, time-based restrictions on vesting, and/or restrictions under applicable securities laws.

 

(4)               
Consideration. The Committee shall determine the amount, if any, that a Grantee shall pay for Restricted Shares. Such
payment shall be made in full by the Grantee before the delivery of the Shares or Share Units and in any event no later than 10
business days after the Grant Date for such Shares or Share Units.

 

(5)               
Effect of Forfeiture. Unless otherwise provided in the Award Agreement, if Restricted Shares are forfeited, and if the
Grantee was required to pay for such Shares or Share Units or acquired such Restricted Shares upon the exercise of an Option, the
Grantee shall be deemed to have resold such Restricted Shares to the Company at a price equal to the lesser of (x) the amount paid
by the Grantee for such Restricted Shares, or (y) the Fair Market Value of a Share or Share Unit on the date of such forfeiture.
The Company shall pay to the Grantee the required amount as soon as is administratively practical. Such Restricted Shares shall
cease to be outstanding and shall no longer confer on the Grantee thereof any rights as a stockholder of the Company, from and
after the date of the event causing the forfeiture, whether or not the Grantee accepts the Company’s tender of payment for
such Restricted Shares.

 

(6)               
Escrow; Legends. The Committee may provide that the certificates for any Restricted Shares (x) shall be held (together
with a stock power executed in blank by the Grantee) in escrow by the Secretary of the Company until such Restricted Shares become
nonforfeitable or are forfeited and/or (y) shall bear an appropriate legend restricting the transfer of such Restricted Shares.
If any Restricted Shares become non-forfeitable, the Company shall cause any certificates for such Shares to be issued without
such legend.

 

Article 9 

 

OTHER
AWARDS

 

The
Committee may grant Other Awards that are payable in cash, Shares or other securities or property (or any combination thereof)
as deemed by the Committee to be consistent with the purposes of the Plan, and such Other Awards shall be subject to the terms,
conditions, restrictions and limitations determined by the Committee, in its sole discretion, from time to time. Other Awards may
be granted with value and payment contingent upon the achievement of performance criteria. Other Awards may also be granted in
the form of mutual fund units that are credited with income, gains and losses based on the performance of certain mutual fund investment
options.

 

Article 10

BENEFICIARY DESIGNATION

 

Each Grantee under the Plan may, from time
to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under the Plan
is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke
all prior designations by the same Grantee, shall be in a form prescribed by the Company, and will be effective only when filed
by the Grantee in writing with the Company during the Grantee’s lifetime. In the absence of any such designation, benefits
remaining unpaid at the Grantee’s death shall be paid to the Grantee’s estate.

 

    11

     

    

 

Article 11

 

DEFERRALS

 

The Committee may require or permit Grantees
to elect to defer the receipt of the payment of cash or the delivery of Shares that would otherwise be due by virtue of the exercise
of an Option or SAR or the lapse or waiver of restrictions with respect to Restricted Shares under such rules and procedures as
established under the Plan or such other rules and procedures as the Committee shall establish; provided, however, to the extent
that such deferral is subject to Section 409A of the Code the rules and procedures established by the Committee shall comply with
Section 409A of the Code. Except as otherwise provided in an Award Agreement, any payment or any Shares that are subject to such
deferral shall be made or delivered to the Grantee upon the Grantee’s Termination of Affiliation.

 

Article 12

 

RIGHTS OF EMPLOYEES/DIRECTORS/CONSULTANTS

 

(1)               
Employment. Nothing in the Plan shall interfere with or limit in any way the right of the Company or any Subsidiary
to terminate any Grantee’s employment, directorship or consultancy at any time, nor confer upon any Grantee the right to
continue in the employ or as a director or consultant of the Company or any Subsidiary.

 

(2)               
Participation. No employee, director or consultant shall have the right to be selected to receive an Award under the
Plan or, having been so selected, to be selected to receive a future Award.

 

(3)               
Dividend Equivalents. Subject to the provisions of the Plan and any Award, the recipient of an Award (including any
Award deferred in accordance with procedures established pursuant to Article 11) may, if so determined by the Committee, be entitled
to receive, currently or on a deferred basis, cash, stock or other property dividends, or cash payments in amounts equivalent to
cash, property, or other property dividends on Shares (“Dividend Equivalents”)
with respect to the number of Shares covered by the Award, as determined by the Committee, in its sole discretion, and the Committee
may provide that such amounts (if any) shall be deemed to have been reinvested in additional shares or otherwise reinvested; provided,
however, that if such payment of dividends or Dividend Equivalents would be subject to Section 409A of the Code, no such payment
may be made if it would fail to comply with the requirements set forth in Section 409A of the Code. Notwithstanding the foregoing,
no dividends or Dividend Equivalents will be paid with respect to unvested performance Awards.

 

Article 13

 

AMENDMENT, MODIFICATION AND TERMINATION

 

(1)               
Amendment, Modification, and Termination. Subject to the terms of the Plan, the Board may at any time and from time
to time, alter, amend, suspend or terminate the Plan in whole or in part. To the extent applicable and required by Code Section
422 or the rules of the New York Stock Exchange (or such other exchange upon which the Company lists its shares for trading) or
any other applicable law, rule or regulation, no amendment and no transaction that would constitute a repricing shall be effective
unless approved by the Company’s stockholders. Except in connection with a corporate transaction involving the Company (including,
without limitation, any stock dividend, stock split, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation,
split-up, spin-off, combination, or exchange of shares), the terms of outstanding Awards may not be amended to reduce the exercise
price of outstanding Options or SARs or cancel outstanding Options or SARs in exchange for cash, other Awards or Options or SARs
with an exercise price that is less than the exercise price of the original Options or SARs without stockholder approval. The Board
may delegate to the Plan Committee any or all of the authority of the Board under Section 13.1 to alter, amend, suspend or terminate
the Plan.

 

(2)                Adjustment
of Awards Upon the Occurrence of Certain Unusual or Non-recurring Events. The Committee may make adjustments in the terms
and conditions of, and the criteria included in, Awards in recognition of unusual or non-recurring events (including the
events described in Section 4.2) affecting the Company or the financial statements of the Company or of changes in applicable
laws, regulations, or accounting principles, whenever the Committee determines that such adjustments are appropriate in order
to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan.

 

    12

     

    

 

(3)               
Awards Previously Granted. Notwithstanding any other provision of the Plan to the contrary, no termination, amendment
or modification of the Plan shall adversely affect in any material way any Award previously granted under the Plan, without the
written consent of the Grantee of such Award. Without limiting the generality of the foregoing, the Plan as amended and restated
as set forth herein as of the Effective Date shall not adversely impact in any way any Award previously granted under the Plan
prior to the Effective Date.

 

Article 14

 

WITHHOLDING

 

(1)               
Withholding. Each Grantee shall, no later than the date as of which the value of
an Award first becomes includible in the gross income of such Grantee for federal and/or state income tax purposes, pay to the
Company, or make arrangements satisfactory to the Management Committee (or the Committee to the extent required by Section 16(b)
of the Exchange Act) regarding payment of, any federal, state, or local taxes of any kind required by law to be withheld with respect
to the Award. The obligations of the Company under the Plan shall be conditional on the making of such payments or arrangements,
and the Company shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise
due to such Grantee. Whenever cash is to be paid pursuant to an Award granted hereunder, the Company shall have the right to deduct
therefrom an amount sufficient to satisfy any federal, state and local withholding tax requirements related thereto. Whenever Shares
(or other property) are to be delivered pursuant to an Award, the Company shall have the right to require the Grantee to remit
to the Company in cash an amount sufficient to satisfy any related federal, state and local taxes to be withheld and applied to
the tax obligations. With the approval of the Management Committee (or the Committee to the extent required by Section 16(b) of
the Exchange Act), a Grantee may satisfy the foregoing requirement by electing to have the Company withhold from delivery of Shares
(or other property) or by delivering already owned unrestricted Shares, in each case, having a value not exceeding the federal,
state and local taxes to be withheld and applied to the tax obligations. Such Shares or other property shall be valued at their
Fair Market Value on the date of which the amount of tax to be withheld is determined. Fractional share amounts shall be settled
in cash. Such an election may be made with respect to all or any portion of the Shares or other property to be delivered pursuant
to an Award. The Company may also use any other method of obtaining the necessary payment or proceeds, as permitted by law, to
satisfy its withholding obligation with respect to any Award.

 

(2)               
Notification under Code Section 83(b). If the Grantee, in connection with the exercise of any Option, or the grant
of Restricted Shares, makes the election permitted under Section 83(b) of the Code to include in such Grantee’s gross income
in the year of transfer the amounts specified in Section 83(b) of the Code, then such Grantee shall notify the Company of such
election within 10 days of filing the notice of the election with the Internal Revenue Service, in addition to any filing and
notification required pursuant to regulations issued under Section 83 (b) of the Code. The Committee may, in connection with the
grant of an Award or at any time thereafter prior to such an election being made, prohibit a Grantee from making the election
described above. 

 

Article 15

 

SUCCESSORS

 

All obligations of the Company under the
Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such successor
is the result of a direct or indirect purchase, merger, consolidation, or otherwise of all or substantially all of the business
and/or assets of the Company.

 

    13

     

    

 

Article 16

 

ADDITIONAL PROVISIONS

 

(1)               
Gender and Number. Except where otherwise indicated by the context, any masculine term used herein also shall include
the feminine, the plural shall include the singular and the singular shall include the plural.

 

(2)               
Severability. If any part of the Plan is declared by any court or governmental authority to be unlawful or invalid,
such unlawfulness or invalidity shall not invalidate any other part of the Plan. Any Section or part of a Section so declared to
be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part
of a Section to the fullest extent possible while remaining lawful and valid.

 

(3)               
Requirements of Law. The granting of Awards and the issuance of Shares under the Plan shall be subject to all applicable
laws, rules and regulations, and to such approvals by any governmental agencies or stock exchanges as may be required. Notwithstanding
any provision of the Plan or any Award, Grantees shall not be entitled to exercise, or receive benefits under, any Award, and the
Company shall not be obligated to deliver any Shares or other benefits to a Grantee, if such exercise or delivery would constitute
a violation by the Grantee or the Company of any applicable law or regulation.

 

(4)               
Securities Law Compliance.

 

(a)           
If the Committee deems it necessary to comply with any applicable securities law, or the requirements of any stock exchange
upon which Shares may be listed, the Committee may impose any restriction on Shares acquired pursuant to Awards under the Plan
as it may deem advisable. All certificates for Shares delivered under the Plan pursuant to any Award or the exercise thereof shall
be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations
and other requirements of the SEC, any stock exchange upon which Shares are then listed, any applicable securities law, and the
Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions.
If so requested by the Company, the Grantee shall make a written representation to the Company that he or she will not sell or
offer to sell any Shares unless a registration statement shall be in effect with respect to such Shares under the Securities Act
of 1993, as amended (the “Securities Act”), and any applicable state
securities law or unless he or she shall have furnished to the Company evidence satisfactory to the Company that such registration
is not required.

 

(b)           
If the Committee determines that the exercise or non-forfeitability of, or delivery of benefits pursuant to, any Award would
violate any applicable provision of securities laws or the listing requirements of any stock exchange upon which any of the Company’s
equity securities are listed, then the Committee may postpone any such exercise, non-forfeitability or delivery, as applicable,
but the Company shall use all reasonable efforts to cause such exercise, non-forfeitability or delivery to comply with all such
provisions at the earliest practicable date.

 

(5)               
No Rights as a Stockholder. A Grantee shall not have any rights as a stockholder of the Company with respect to the
Shares (other than Restricted Shares) which may be deliverable upon exercise or payment of such Award until such shares have been
delivered to him or her. Restricted Shares, whether held by a Grantee or in escrow by the Secretary of the Company, shall confer
on the Grantee all rights of a stockholder of the Company, except as otherwise provided in the Plan or Award Agreement. At the
time of a grant of Restricted Shares, the Committee may require the payment of cash dividends thereon to be deferred and, if the
Committee so determines, reinvested in additional Restricted Shares. Stock dividends and deferred cash dividends issued with respect
to Restricted Shares shall be subject to the same restrictions and other terms as apply to the Restricted Shares with respect to
which such dividends are issued. The Committee may provide for payment of interest on deferred cash dividends.

 

    14

     

    

 

(6)                Nature
of Payments. Awards shall be special incentive payments to the Grantee and shall not be taken into account in computing
the amount of salary or compensation of the Grantee for purposes of determining any pension, retirement, death or other
benefit under (a) any pension, retirement, profit-sharing, bonus, insurance or other employee benefit plan of the Company or
any Subsidiary or (b) any agreement between (i) the Company or any Subsidiary and (ii) the Grantee, except as such plan or
agreement shall otherwise expressly provide.

 

(7)               
Governing Law. The Plan, and all agreements hereunder, shall be construed in accordance with and governed by the laws
of the State of Delaware other than its laws respecting choice of law.

 

(8)               
Status as Foreign Private Issuer. As of the Effective Date and for a certain period of time thereafter, the Company
will qualify as a “foreign private issuer” (as defined in Rule 405 of the Securities Act and Rule 3b-4 of the Exchange
Act), which permits the Company to operate the Plan, and to grant Awards and issue Shares under the Plan, under different laws,
rules or regulations than those that may be expressly referenced herein. Notwithstanding any provision of the Plan or an Award
Agreement to the contrary, the Plan shall only be required to be administered in compliance with applicable laws, rules and regulations.
However, the Committee, if it deems it necessary or advisable, may decide in its discretion to administer the Plan in compliance
with such laws, rules and regulations as may become applicable upon the Company ceasing to qualify as a foreign private issuer.

 

(9)               
Code Section 409A Compliance. The intent of the Company is that payments and benefits under this Plan comply with Section
409A of the Code to the extent subject thereto, and, accordingly, to the maximum extent permitted, this Plan shall be interpreted
and be administered to be in compliance therewith. Any payments described in this Plan that are due within the “short term
deferral period” as defined in Section 409A of the Code shall not be treated as deferred compensation unless applicable law
requires otherwise. Notwithstanding anything to the contrary in this Plan, to the extent required in order to avoid accelerated
taxation and/or tax penalties under Section 409A of the Code, amounts that would otherwise be payable and benefits that would otherwise
be provided pursuant to this Plan during the six-month period immediately following the Grantee’s termination of employment
shall instead be paid on the first business day after the date that is six months following the Grantee’s separation from
service (or upon Grantee’s death, if earlier). In addition, for purposes of this Plan, each amount to be paid or benefit
to be provided to the Grantee pursuant to the Plan, which constitute deferred compensation subject to Section 409A of the Code,
shall be construed as a separate identified payment for purposes of Section 409A of the Code.

 

    15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}]]